The landscape of chronic liver disease has drastically changed over the past 20 years,
largely due to advances in antiviral therapy and the rise of metabolic syndrome and …

Cryptogenic cirrhosis (CC) is the end stage of a chronic liver disease in which its underlying
etiology remains unknown after extensive clinical, serological, and pathological evaluations …

Due to pandemic of over-nutrition and its related metabolic risks including central obesity,
glucose intolerance, dyslipidaemia and hypertension, non-alcoholic fatty liver disease …

肝硬化是各类慢性肝病发展的终末阶段, 常见的病因包括慢性病毒性肝炎, 非酒精性脂肪性肝病,
自身免疫性肝病, 遗传代谢性肝病等. 明确病因诊断是对因治疗的重要前提.“不明原因” …

Introduction Cryptogenic chronic hepatitis is a growing cause of liver transplants, affecting
5%–15% of patients with chronic liver diseases. This study aimed to identify underlying …

Interventions: Both patients received intramuscular injections of vitamin B12. Outcomes:
Hemoglobin levels of the 2 patients increased gradually, and their neurological symptoms …

Liver cirrhosis is the final stage of various chronic liver diseases, and the common etiologies
of liver cirrhosis include chronic viral hepatitis, nonalcoholic fatty liver disease, autoimmune …

Solid-organ transplant is one of the most complex areas of modern medicine involving
surgery. There are challenging opportunities in solid-organ transplant, specifically regarding …

Objective: End-stage liver disease (ESLD) is a devastating condition, which leads to liver
transplantation (LT). There are various proposed predisposing factors for ESLD. A significant …

Introducción y objetivo. La deficiencia de lipasa ácida lisosomal (LAL-D) se puede
relacionar con cirrosis por esteatohepatitis no alcohólica (NASH). Muchas de las cirrosis …